A. Rodríguez

1.8k total citations
44 papers, 1.3k citations indexed

About

A. Rodríguez is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Immunology. According to data from OpenAlex, A. Rodríguez has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Public Health, Environmental and Occupational Health, 21 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in A. Rodríguez's work include Research on Leishmaniasis Studies (31 papers), Trypanosoma species research and implications (17 papers) and Toxin Mechanisms and Immunotoxins (4 papers). A. Rodríguez is often cited by papers focused on Research on Leishmaniasis Studies (31 papers), Trypanosoma species research and implications (17 papers) and Toxin Mechanisms and Immunotoxins (4 papers). A. Rodríguez collaborates with scholars based in Spain, United States and United Kingdom. A. Rodríguez's co-authors include Jordi Alberola, Laia Solano‐Gallego, Olga Francino, Xavier Roura, Laura Altet, Lluís Ferrer, Ana Ojeda, Armand Sánchez, Marcos Timón and Laura López-Fuertes and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

A. Rodríguez

41 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Rodríguez Spain 21 1.1k 697 386 187 149 44 1.3k
Jordi Alberola Spain 26 2.0k 1.9× 1.2k 1.7× 751 1.9× 308 1.6× 251 1.7× 51 2.4k
Iván Marcipar Argentina 17 394 0.4× 537 0.8× 158 0.4× 90 0.5× 117 0.8× 78 870
Hatice Ertabaklar Türkiye 19 542 0.5× 267 0.4× 425 1.1× 214 1.1× 37 0.2× 108 1.1k
Poornima Ramanan United States 14 356 0.3× 352 0.5× 155 0.4× 300 1.6× 62 0.4× 30 944
Christelle Pomarès France 20 644 0.6× 725 1.0× 685 1.8× 364 1.9× 40 0.3× 64 1.4k
Richard W. Finley United States 15 309 0.3× 152 0.2× 265 0.7× 287 1.5× 66 0.4× 31 955
Anastácio Q. Sousa Brazil 8 518 0.5× 478 0.7× 148 0.4× 255 1.4× 58 0.4× 14 898
Luiz Cosme Cotta Malaquias Brazil 18 399 0.4× 290 0.4× 299 0.8× 170 0.9× 151 1.0× 58 955
P. Abranches Portugal 19 891 0.8× 599 0.9× 297 0.8× 114 0.6× 98 0.7× 36 1.0k
Abdolmajid Fata Iran 18 278 0.3× 381 0.5× 154 0.4× 302 1.6× 40 0.3× 89 951

Countries citing papers authored by A. Rodríguez

Since Specialization
Citations

This map shows the geographic impact of A. Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Rodríguez more than expected).

Fields of papers citing papers by A. Rodríguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Rodríguez. The network helps show where A. Rodríguez may publish in the future.

Co-authorship network of co-authors of A. Rodríguez

This figure shows the co-authorship network connecting the top 25 collaborators of A. Rodríguez. A scholar is included among the top collaborators of A. Rodríguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Rodríguez. A. Rodríguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rodríguez, A., et al.. (2024). IgA Vasculitis Associated With Levofloxacin Use in an Adult Female: A Case Report. Cureus. 16(10). e71567–e71567.
3.
Gállego, Montserrat, et al.. (2021). Vitamin d and leishmaniasis: Neither seasonal nor risk factor in canine host but potential adjuvant treatment through cbd103 expression. PLoS neglected tropical diseases. 15(8). e0009681–e0009681. 5 indexed citations
4.
Cortes-Serra, Núria, Ana Rodrı́guez, Joaquím Gascón, et al.. (2021). Anti-Trypanosoma cruzi Activity of Metabolism Modifier Compounds. International Journal of Molecular Sciences. 22(2). 688–688. 18 indexed citations
5.
Monteagudo, Paula L., et al.. (2020). Sirolimus enhances the protection achieved by a DNA vaccine against Leishmania infantum. Parasites & Vectors. 13(1). 294–294. 2 indexed citations
6.
Ty, Maureen, P’ng Loke, Jordi Alberola, Ana Rodrı́guez, & A. Rodríguez. (2019). Immuno-metabolic profile of human macrophages after Leishmania and Trypanosoma cruzi infection. PLoS ONE. 14(12). e0225588–e0225588. 21 indexed citations
7.
Rodríguez, A., Eugenia Carrillo, Ana Ojeda, et al.. (2016). Compartmentalized Immune Response in Leishmaniasis: Changing Patterns throughout the Disease. PLoS ONE. 11(5). e0155224–e0155224. 21 indexed citations
8.
9.
Rodríguez, A., et al.. (2012). Performance of commercially available serological diagnostic tests to detect Leishmania infantum infection on experimentally infected dogs. Veterinary Parasitology. 191(3-4). 363–366. 36 indexed citations
10.
Rodríguez, A., Marı́a del Carmen Núñez, Márcia Dalastra Laurenti, et al.. (2012). Head-to-Head Comparison of Three Vaccination Strategies Based on DNA and Raw Insect-Derived Recombinant Proteins against Leishmania. PLoS ONE. 7(12). e51181–e51181. 11 indexed citations
11.
Galindo, Inmaculada, Silvia Gómez-Sebastián, Mariano Pérez-Filgueira, et al.. (2010). Dynamics and Predictive Potential of Antibodies against Insect-Derived Recombinant Leishmania infantum Proteins during Chemotherapy of Naturally Infected Dogs. American Journal of Tropical Medicine and Hygiene. 82(5). 795–800. 7 indexed citations
12.
Solano‐Gallego, Laia, Marı́a del Carmen Núñez, Rodrigo Lasa, et al.. (2010). Humoral and In Vivo Cellular Immunity against the Raw Insect-Derived Recombinant Leishmania infantum Antigens KMPII, TRYP, LACK, and papLe22 in Dogs from an Endemic Area. American Journal of Tropical Medicine and Hygiene. 83(6). 1287–1294. 7 indexed citations
13.
Pérez-Filgueira, Mariano, Inmaculada Galindo, Silvia Gómez-Sebastián, et al.. (2009). Seroreactivity against raw insect-derived recombinant KMPII, TRYP, and LACK Leishmania infantum proteins in infected dogs. Veterinary Parasitology. 164(2-4). 154–161. 13 indexed citations
14.
Solano‐Gallego, Laia, Ana Ojeda, Josefina Quintana, et al.. (2008). Anti-Leishmania IgA in urine samples from dogs with clinical leishmaniasis. Veterinary Parasitology. 159(1). 17–23. 16 indexed citations
15.
Fernández-Bellón, Hugo, Laia Solano‐Gallego, A. Rodríguez, et al.. (2008). Little evidence of seasonal variation of natural infection by Leishmania infantum in dogs in Spain. Veterinary Parasitology. 155(1-2). 32–36. 20 indexed citations
16.
Rodríguez, A., Ana Ojeda, Laura López-Fuertes, et al.. (2007). Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge. Vaccine. 25(46). 7962–7971. 51 indexed citations
17.
Francino, Olga, Laura Altet, Armand Sánchez, et al.. (2006). Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis. Veterinary Parasitology. 137(3-4). 214–221. 329 indexed citations
18.
Rodríguez, A., Ana Ojeda, Laura López-Fuertes, et al.. (2006). A long term experimental study of canine visceral leishmaniasis. International Journal for Parasitology. 37(6). 683–693. 68 indexed citations
19.
Fernández-Bellón, Hugo, Laia Solano‐Gallego, A. Rodríguez, et al.. (2005). Comparison of three assays for the evaluation of specific cellular immunity to Leishmania infantum in dogs. Veterinary Immunology and Immunopathology. 107(1-2). 163–169. 27 indexed citations
20.
Bouza, José Marı́a Eiros, et al.. (2002). Virus emergentes en nefrología: poliomavirus. Nefrología. 22(5). 414–424. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jordi Alberola Breakdown of academic impact, for papers by Iván Marcipar Breakdown of academic impact, for papers by Hatice Ertabaklar Breakdown of academic impact, for papers by Poornima Ramanan Breakdown of academic impact, for papers by Christelle Pomarès Breakdown of academic impact, for papers by Richard W. Finley Breakdown of academic impact, for papers by Anastácio Q. Sousa Breakdown of academic impact, for papers by Luiz Cosme Cotta Malaquias Breakdown of academic impact, for papers by P. Abranches Breakdown of academic impact, for papers by Abdolmajid Fata
Rankless by CCL
2026